The QualityStocks Daily Tuesday, October 2nd, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (OGEN) +123.13%

QualityStocks (FPVD) +100.00%

NetworkNewsWire (CIIX) +55.30%

The QualityStocks Daily Stock List

HCi Viocare (VICA)

MarketWatch and Financial Times reported previously on HCi Viocare (VICA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

HCi Viocare focuses on the development and marketing of prosthetics and orthotics. The Company has a strong pipeline of near-market to research-stage technologies. HCi Viocare has its executive office in Athens, Greece, and its research and development (R&D) center in Glasgow, Scotland, United Kingdom (UK). The Company’s shares trade on the OTC Markets’ OTCQB.

HCi Viocare has two fully owned subsidiaries. One is HCi Viocare Technologies. The other is HCi Viocare Clinics. HCi Viocare Technologies is developing hardware solutions aiming to empower the user through providing on demand information and enhancing living quality.

HCi Viocare’s business model consists of creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe and the Middle East and developing an extensive portfolio of proprietary hardware solutions with first in line the Flexisense™ sensor system. The clinics will provide independent and personalized quality of care for its patients. The first HCi Viocare clinic has been operating since September 2015 in Glasgow.

The R&D center is working on a large portfolio of progressive, cutting-edge, and disruptive technologies in the Digital Health, Prosthetics, and Orthotics, Diabetes, Assistive Devices and Sports & Wellbeing fields. HCi Viocare has developed a unique sensing technology with the brand name Flexisense™.

Flexisense™ technology is the next generation of sensing technologies for wearable devices. Flexisense™ is an inventive sensing technology. It measures pressure and shear forces. In addition, it provides on demand information wirelessly. Flexisense can be incorporated in a wide array of applications.

The Company has developed a new application for its sensing technology Flexisense™, now for automotive tires. Flexisense™ applied to tires can monitor, in real time, tire deformation and actual traction between the tire and the ground.

HCi Viocare Management, acknowledging the great advantages of Blockchain technology, has decided to develop its own proprietary Blockchain based system for handling the sensitive client records in its Scottish Clinics subsidiary. This team will develop a proprietary Blockchain based system for handling and storing the data produced from the medical applications of its Flexisense™ technology.

In October of 2017, HCi Viocare welcomed Dr. John Doupis, MD, PhD to its team. Dr. Doupis joined the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center, Harvard Medical School, in Boston, Massachusetts, and Scientific partner in Beth Israel Deaconess Foot Center Harvard Medical School, Boston, Massachusetts. Dr. Doupis’ special areas of interest are Diabetes and its complications, particularly the Diabetic foot and Obesity.

HCi Viocare (VICA), closed Tuesday's trading session at $0.705, up 19.29%, on 600 volume with 4 trades. The average volume for the last 3 months is 2,435 and the stock's 52-week low/high is $0.425/$2.759.

chart

Aurania Resources Ltd. (AUIAF)

Penny Stock Hub, StockCharts, Streetwise Reports, Stockwatch, OTC Markets, Wallet Investor, 4-Traders, MarketWatch, Stockhouse, Barchart, GuruFocus, Morningstar, Investors Hangout, Investing News Alerts, TradingView, and Junior Mining Network reported on Aurania Resources Ltd. (AUIAF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Aurania Resources Ltd. is a junior exploration mining company listed on the OTC Markets Group’s OTCQB. The Company engages in the identification, evaluation, acquisition and exploration of mineral property interests. Its emphasis is on precious metals and copper. Aurania Resources has its corporate office in Toronto, Ontario.

The Company’s flagship asset is The Lost Cities-Cutucu Project. It is situated in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador. The Lost City Project is in the south-eastern part of the Republic of Ecuador, in the Province of Morona-Santiago.

The Project consists of circa 208,000 hectares in 42 concessions occupying the central part of the Cordillera de Cutucu.  The concessions extend about 95 km along the Cordillera.

Furthermore, Aurania has three projects in Canton Valais, Switzerland. These are Siviez (Uranium, Copper and Gold), Marécottes (Uranium), and Mont Chemin (Gold). All of these projects are 100 percent held via the Company’s wholly-owned subsidiary AuroVallis SARL.

At the end of May, Aurania Resources reported the discovery of a new epithermal zone approximately eight kilometers south of the "Crunchy Hill" region. This new discovery is called "Yawi".

Furthermore, two diatremes (breccia bodies) were found in close by outcrop. The Company states that presumably there is a geological connection between the diatremes and the mineralization.

Rocks in the area are clay-and sericite-altered.  Preliminary XRF (x-ray fluorescence) analysis indicates anomalously high levels of mercury and arsenic in selected samples. These are natural pathfinder elements for precious metals. They can be used to vector in to the mineralization.

Aurania's Chairman and Chief Executive Officer, Dr. Keith Barron, said, “The samples from Yawi that have been collected to date have the most impressive epithermal textures I have seen in my career, and the Latorre area contains anomalous levels of arsenic, antimony, mercury, selenium, thallium and silver.”

Aurania Resources Ltd. (AUIAF), closed Tuesday's trading session at $1.84133, up 8.37%, on 12,048 volume with 25 trades. The average volume for the last 3 months is 6,424 and the stock's 52-week low/high is $1.025/$6.06.

chart

Repro Med Systems, Inc. (REPR)

Zacks, Market Exclusive, Streetwise Reports, Equity Clock, Marketbeat, Business Wire, Simply Wall St, Stockhouse, 4-Traders, Street Insider, and Stock News Times reported on Repro Med Systems, Inc. (REPR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Repro Med Systems, Inc. (d/b/a RMS Medical Products) develops, manufactures and commercializes medical products used for home infusions and suctioning. The Company is a foremost developer and manufacturer of medical devices and supplies. It focuses on designing and manufacturing safe, affordable medical devices to make quality healthcare a reality for all.

The Company’s products, as well as product support, are provided globally by RMS and via an international network of distributors and service providers. Repro Med Systems’ shares trade on the OTCQX. The Company has its corporate headquarters in Chester, New York.

Repro Med Systems’ main products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™, and RES-Q-VAC® Hand Held Medical Suction.

The FREEDOM Syringe Infusion System presently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional healthcare settings and also at home. Repro Med's RES-Q-VAC® line of medical suctioning products is used by emergency medical service providers in addition to an array of other healthcare providers.

The Company’s products do not rely on batteries or electric power. Therefore, this makes them dependable in critical situations. Repro Med Systems specializes in developing and manufacturing portable medical devices and supplies for a broad spectrum of markets. This includes hospitals, home healthcare, nursing homes, as well as rescue services.

Recently, Repro Med Systems (d/b/a RMS Medical Products) announced that the United States Court of Appeals for the Federal Circuit shot down EMED's appeal and that nine of the ten claims in EMED's patent were invalid. The Company and EMED have been involved in continuing litigation for some time.

On April 3, 2018 the CAFC issued its decision. The CAFC's Judgement affirmed the Final Written Decision of the PTAB invaliding claims 1-8 and 10 of EMED's '476 patent.

Mr. Andy Sealfon, RMS Chief Executive Officer, said, "The court's decision further validates RMS's leading status as an innovator in home infusion. While we are pleased with the result, we want to assure our partners that despite all of this unwarranted legal interference, RMS remains focused on its mission to improve the quality of life of patients around the world."

Repro Med Systems, Inc. (REPR), closed Tuesday's trading session at $1.75, up 5.45%, on 22,085 volume with 25 trades. The average volume for the last 3 months is 19,109 and the stock's 52-week low/high is $0.4925/$1.79.

chart

Cornerstone Metals, Inc. (CCCCF)

StockPulse, Penny Stock Hub, Stockwatch, Market News Updates, Stockhouse, Geology for Investors, Business Insider, MarketWatch, The Prospector News, OTC Markets, Morningstar, TradingView, Metals Channel, Barchart, Market Trend News, 4-Traders, Investors Hangout, Wallmine, and 24hgold reported on Cornerstone Metals, Inc. (CCCCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cornerstone Metals, Inc. engages in the acquisition, exploration, and development of mineral properties in the U.S. and Canada. The Company’s Carlin Vanadium Project hosts one of North America’s largest, richest, primary Vanadium deposits, located in Nevada. Its West Jerome project targets a large scale high grade copper and zinc deposit in Arizona. Cornerstone Metals is headquartered in Vancouver, British Columbia. The Company lists on the OTC Markets’ OTCQB.

Cornerstone Metals has an option to earn a 100 percent interest in the Carlin Vanadium Project situated in Elko County, 14 miles from the town of Carlin, Nevada. The project consists of 72 contiguous unpatented mineral claims totaling 461 hectares (1,140 acres).

The Carlin Vanadium deposit was discovered by Union Carbide Corp. in the 1960’s, completing 127 rotary drill holes systematically defining near surface shallow dipping deposit. Carlin is a major rail hub to the East and West Coasts.

The Carlin Vanadium Project hosts the Carlin Vanadium Deposit that is flat to shallow dipping and at shallow depths, usually between 0-60m (0-200 ft) below surface. Cornerstone Metals is fast tracking this project. The Company is aiming for a one year timeline from “rediscovery” to Indicated Resource, to quickly unlock potential project value.

Cornerstone Metals also has its West Jerome Project. The West Jerome Property focuses in the copper-rich district of Arizona, close to the Town of Jerome, Central Arizona. The West Jerome property comprises roughly five square kilometers of claims on the west side of Freeport McMoran patented lands.

A Volcanogenic Sulfide camp, the Property is a high-grade, massive sulfide target positioned 2.4 km south of the past-producing United Verde Mine. Cornerstone Metals retains a 100 percent interest in the Project.

Last week, Cornerstone Metals announced additional preliminary results of metallurgical test work taking place on its Carlin Vanadium Project in Nevada. The third round of testing has attained vanadium extraction levels of 95.5 percent. Test work continues on a sample composite generated from an 18.9 meter drill core intercept from Cornerstone’s recent diamond drilling verification program on the deposit.

Cornerstone Metals, Inc. (CCCCF), closed Tuesday's trading session at $1.2291, up 5.96%, on 78,010 volume with 71 trades. The average volume for the last 3 months is 52,906 and the stock's 52-week low/high is $0.135/$1.41.

chart

Oncolix, Inc. (ONCX)

Dividend Investor, Investopedia, Barchart, Stockhouse, SmallCapVoice, Stockwatch, OTC Markets, Stockopedia, and InvestorsHub reported on Oncolix, Inc. (ONCX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Oncolix, Inc. is developing Prolanta™ for the treatment of ovarian, uterine, breast, and other cancers. A clinical-stage biotechnology company, Oncolix has a US FDA-cleared (Food and Drug Administration) IND to begin human testing of Prolanta™ in its first indication, the treatment of ovarian cancer. The Phase 1 clinical trial is now in progress. Oncolix is based in Houston, Texas. The Company lists on the OTC Markets Group’s OTCQB.

Oncolix believes Prolanta™ has the opportunity to treat a broad spectrum of human cancers. The Company states that there is substantial scientific evidence that human prolactin is associated with the growth of numerous cancers and also the development of resistance to common chemotherapies. Oncolix believes Prolanta™ will be effective against many cancers as a stand-alone therapy as well as part of combination therapy.

Prolanta™ is a prolactin receptor antagonist (or blocker).  Prolanta™ has demonstrated efficacy in xenograft models through an innovative mechanism of action, autophagy. There is strong preclinical evidence Prolanta™ may be effective in breast, prostate, and other cancers, in addition to ovarian cancer.  

Prolanta™ is undergoing evaluation in an open-label dose escalation Phase 1 clinical trial in patients with advanced ovarian cancer. Patients are divided into three dosing groups (cohorts). Each sequential cohort will evaluate a higher dose of Prolanta™.

In the present Phase 1 dose-escalation safety trial for the treatment of ovarian cancer, so far there have been no observed serious adverse events. Additionally, there have been no dose-limiting toxicities. The FDA has approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer.

Oncolix announced in January 2018 that it sponsored additional research with MD Anderson Cancer Center. The research will evaluate Prolanta™ for the potential treatment of additional gynecological cancers, more specifically uterine cancer.

Last week, Oncolix announced that Mr. Andrew Scott has joined the Company as its Vice President of Corporate Development. Mr. Scott has approximately 20 years experience as an Investment Banker. His emphasis over the past eight years has been on small companies in the life sciences arena.

Mr. Michael T. Redman, Oncolix’s President and Chief Executive Officer, said, "We are counting on Andrew to help take the company from its current status to a NASDAQ-listed company in 2019. His knowledge of the investment community should help Oncolix navigate potential capital raises, strategic alliances and expand awareness in the investor community with a planned future uplisting."

Oncolix, Inc. (ONCX), closed Tuesday's trading session at $0.01224, up 15.47%, on 100 volume with 1 trade. The average volume for the last 3 months is 96,976 and the stock's 52-week low/high is $0.0065/$0.0888.

chart

ZIVO Bioscience, Inc. (ZIVO)

RedChip, Marketbeat, Street Insider, Business Insider, Wallet Investor, Zacks, Ceocast News, MarketWatch, and Marketwired reported previously on ZIVO Bioscience, Inc. (ZIVO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ZIVO Bioscience, Inc.’s commitment is to the development and commercialization of nutritional compounds and bioactive molecules derived from its proprietary algal strains. In addition, ZIVO engages in the development of natural bioactive compounds for use as dietary supplements and food ingredients, and biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation.

ZIVO Bioscience is headquartered in Keego Harbor, Michigan. The Company’s wholly-owned subsidiary is WellMetris, LLC.

ZIVO Bioscience is re-inventing itself as a licensor of internally developed intellectual property (IP) that includes its proprietary algae cultures, in addition to IP secured by way of strategic acquisitions. The Company is a biotech/agtech R&D company involved in the commercialization of nutritional and medicinal products derived from proprietary algal strains.

ZIVO Bioscience works to completely harness the beneficial effects of its natural bioactive agents and make them affordable and readily available in a useful and convenient form. It has more recently continued to focus almost exclusively on dairy cow applications for its proprietary algal biomass, extracts and any high-value bioactive compounds thereof. This is while developing the business case and production scale-up to cultivate and productize the algal biomass.

The Company’s core IP consists of the algae culture itself, the patented process of producing that culture, and the bioactive compounds or molecules that can be extracted, and also the application of that culture or extract in supporting health maintenance and longevity. ZIVO’s plan is to approach the near-term markets first: animal applications, human food ingredients and human dietary supplements.

Earlier this month, ZIVO Bioscience announced that it received positive results from a discovery-stage efficacy pilot experiment designed to test the efficacy of certain lead compounds against well-known bacterial infections that cause bovine mastitis. This latest experiment builds on earlier in vitro research and an in vivo efficacy study that showed that bioactive compounds produced by ZIVO’s proprietary strain of algae showed efficacy in fighting the effects of bovine mastitis caused by mycoplasma bovis (a drug-resistant infective pathogen).

Last week, ZIVO Bioscience announced that Mr. Ronald C. Costephens joined the Company as Vice-President- Global Operations. Mr. Costephens responsibilities include building out a worldwide supply chain and an organization to help transition ZIVO Bioscience from an R&D entity into an operating business, which will engage in the licensing of its IP portfolio, and also in handling the production and distribution of bulk and finished food, beverage and feed products featuring its proprietary algal strains.

ZIVO Bioscience, Inc. (ZIVO), closed Tuesday's trading session at $0.17, up 6.25%, on 44,000 volume with 4 trades. The average volume for the last 3 months is 80,270 and the stock's 52-week low/high is $0.002/$0.189.

chart

Acacia Diversified Holdings, Inc. (ACCA)

Daily Marijuana Observer, Real Pennies, and InvestorsHub reported earlier on Acacia Diversified Holdings, Inc. (ACCA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Acacia Diversified Holdings, Inc. is an emerging cannabis business headquartered in Clearwater, Florida. The Company’s wholly-owned subsidiaries are MariJ Pharmaceuticals, Inc. (MariJ) and Canna-Cures Research & Development Center, Inc. (Canna-Cures). By way of these, Acacia concentrates on the development of new and proprietary medicinal products for patients - with USDA certified organic mobile processing and handling solutions for its customers. Acacia Diversified Holdings’ shares trade on the OTC Markets Group’s OTCQB.

Acacia Diversified Holdings has its Dahlia’s Botanicals product line. Dahlia’s Botanicals sells endocannabinoid nutraceuticals. MariJ is the exclusive organic extraction company and Canna-Cures is the exclusive manufacturer for the Dahlia’s Botanicals line.

MariJ Pharmaceuticals’ focus is on the extraction and processing of very high quality, high-CBD/low-THC content medical grade cannabis oils from medical cannabis plants. MariJ specializes in organic strains of the plant. This sets itself apart from the general producers of non-organic products.

Furthermore, MariJ Pharmaceuticals has the technical expertise and capability to process and formulate the oils and to use them in its compounding operations. In addition, MariJ Pharmaceuticals has its proprietary Geotraking Technology. This technology is totally compliant with the Health Insurance Portability and Accountability standard (HIPAA), using its “plant to patient” solution.

In April 2017, MariJ Pharmaceuticals and Canna-Cures Research & Development Center announced that they successfully completed Phase one of its USDA (United States Department of Agriculture) certified organic processing for Blue Circle Development and organic farm near Ft. Collins, Colorado.

Acacia Diversified Holdings announced in the fall of 2017, by way of its wholly-owned subsidiary, Eufloria Medical of Tennessee, Inc., that Eufloria secured a processing, manufacturing, and retail sales license(s) in the State of Tennessee. The acquisition of these licenses enables Eufloria Medical of Tennessee to conduct hemp-related business in Tennessee. This is as it moves forward in this new developing hemp marketplace.

Acacia Diversified Holdings announced in November of 2017, by way of MariJ Pharmaceuticals, that it received its License to Operate: Manufactured Food Establishment certificate issued on November 8, 2017 by the Colorado Department of Public Health and Environment.

Acacia Diversified Holdings, Inc. (ACCA), closed Tuesday's trading session at $0.24, up 4.35%, on 2,052 volume with 8 trades. The average volume for the last 3 months is 15,126 and the stock's 52-week low/high is $0.1066/$1.00.

chart

Liquidmetal Technologies, Inc. (LQMT)

Greenbackers, SmallCapVoice, PennyStocks24, Pennybuster, SuperNova Elite, Wealth Daily, Marketbeat, Jason Bond, Promotion Stock Secrets, Penny Pro, Winston Small Cap, Wall Street Mover, PennyStocks Forever, and Penny Stocks VIP reported previously on Liquidmetal Technologies, Inc. (LQMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liquidmetal® Technologies, Inc. is the foremost developer of bulk alloys, which use the performance advantages that amorphous alloy technology provides. Amorphous alloys are unique materials distinguished by their ability to retain a random structure when they solidify. This is in comparison to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal® Technologies has its corporate office in Rancho Santa Margarita, California, where the Company also has its Manufacturing Center of Excellence.

Liquidmetal® Technologies is the first company to produce amorphous alloys in commercially viable bulk form. This is enabling critical improvements in products across a wide assortment of industries.

Liquidmetal has two to three times the strength of titanium and stainless steel. It undergoes processing like plastics on the Company's proprietary Liquidmetal molding machines. Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Liquidmetal® Technologies’ alloys are, in many cases, stronger, harder, more elastic, and more wear and corrosion resistant than typically used high-performance alloys.

The Company’s "bulk" amorphous alloys possess advantages normally associated with plastics. These include the ability to undergo molding into precision, complex, and highly finished products. The Company controls the Intellectual Property (IP) rights with greater than 70 U.S. patents.

Liquidmetal® Technologies and the University of Southern California’s M.C. Gill Composites Center are working together to develop an advanced manufacturing process to produce large-scale amorphous metal and fiber laminate sheets for space applications.

For Fiscal Year (FY) 2017, Liquidmetal® Technologies generated $321,000 in Revenue as it continued to concentrate on the development and manufacturing of prototype and commercial parts for its customers and partnering with licensees on the development of its technology and production processes.

This past March, Mr. Bruce Bromage, Liquidmetal® Technologies’ Chief Operating Officer (COO), said, “We made excellent progress in 2017 toward establishing global manufacturing operations for our revolutionary technology. We made significant investments to commercialize our technologies and commission scalable manufacturing facilities. At the same time, we developed our markets through customer prototypes, and streamlined operations with reduced overhead costs…”

Liquidmetal Technologies, Inc. (LQMT), closed Tuesday's trading session at $0.185, up 2.72%, on 433,184 volume with 75 trades. The average volume for the last 3 months is 1,079,353 and the stock's 52-week low/high is $0.161/$0.415.

chart

FieldPoint Petroleum Corp. (FPPP)

Stock Twits, InvestorsHub, OTC Markets, Equity Clock, MarketWatch, and The Street reported on FieldPoint Petroleum Corp. (FPPP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FieldPoint Petroleum Corp. engages in the acquisition, development, and operation of oil and natural gas properties in the U.S. The Company engages in oil and natural gas exploration, production, and acquisition, primarily in Louisiana, New Mexico, Oklahoma, Texas, and Wyoming. FieldPoint Petroleum has its head office in Austin, Texas. The Company lists on the OTCQB.

At present, the Company has varying ownership interests in 480 gross producing wells (96 net) in the above-mentioned States. FieldPoint Petroleum’s strategy focuses on expanding its reserve base. This is while increasing production and cash flow via the acquisition of leasehold interests and producing oil and gas wells.

More recently, FieldPoint Petroleum has chosen to concentrate on promising areas for oil & gas exploration. These areas include the Lusk Field in Lea County, New Mexico, and the Company’s Ranger Project in the Taylor Serbin Field near Giddings, Texas.

In projects like these, FieldPoint Petroleum partners with enterprises that complement internal expertise in evaluate opportunities and in making investment decisions. Concerning producing oil & gas properties, the Company operates 19 wells. Independent contractors operate the other wells per standard industry contracts.

Pertaining to operated wells, FieldPoint Petroleum’s portfolio includes chiefly low-touch, “pumper and electricity-only” wells in the Devonian, Ellenberger, and Morrow areas of West Texas and New Mexico. Higher maintenance fields are closer to home. These include the Taylor Serbin field close to Giddings, Texas. Most of FieldPoint’s production comes from its East Lusk and Serbin Fields.

In Texas, FieldPoint Petroleum is active in Andrews County, Midland County, and Lee & Bastrop Counties. In Louisiana, FieldPoint is active in Caddo Parrish. In Oklahoma, it is active in Grady County and Pontotoc County.

In Wyoming, the Company is active in Converse County and Campbell County. FieldPoint Petroleum is active in Lea County, Chaves County, and Eddy County in New Mexico.

In May, FieldPoint Petroleum announced financial results for its Q1 ended March 31, 2018. Revenues decreased to $492,962 from $838,426. The Company’s Net Loss decreased to ($210,773) from ($409,051). Net Loss per Share decreased - basic to ($0.02) from ($0.04) and fully diluted to ($0.02) from ($0.04).

Mr. Phillip Roberson, FieldPoint Petroleum President and Chief Financial Officer, said, "After this long period of depressed commodity pricing, we are finally seeing some relief. Pricing toward the end of our first quarter reached a manageable level, and if this recovery is sustainable, we expect to be able to further reduce our debt and return to our plan of growth for the company in the near term…”

FieldPoint Petroleum Corp. (FPPP), closed Tuesday's trading session at $0.22, up 13.40%, on 300 volume with 1 trade. The average volume for the last 3 months is 4,251 and the stock's 52-week low/high is $0.10/$0.43.

chart

iAnthus Capital Holdings, Inc. (ITHUF)

InvestorsHub, Stockhouse, MarketWatch, Daily Marijuana Observer, and OTC Markets reported on iAnthus Capital Holdings, Inc. (ITHUF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

iAnthus Capital Holdings, Inc. is a provider of capital investment and management services to licensed cannabis cultivators, processors, and dispensaries throughout the United States. The Company, via its 100 percent owned subsidiary, iAnthus Capital Management, LLC, delivers a complete solution for financing and managing these enterprises. iAnthus supports a varied portfolio of cannabis industry investments. iAnthus Capital Holdings is based in New York, New York.

The Company provides a unique combination of capital and practical operating and management expertise. iAnthus creates agreements that establish valuable partnerships. It has developed strategic partnerships with best-in-class industry-sector leaders in dispensary operations, commercial-scale cannabis cultivation, regulatory law, and the science of cannabis product formulation and testing.

iAnthus Capital Holdings’ current portfolio includes Grassroots Vermont; Mayflower Medicinals, Inc.; Organix, Breckenridge Colorado; and R. Greenleaf Organics. Mayflower Medicinals is a non-profit Massachusetts corporation. It has received two provisional licenses to operate Registered Marijuana Dispensaries (RMDs) in Massachusetts, with a third RMD application pending before the Massachusetts Department of Public Health (DPH).

iAnthus earlier acquired 80 percent of Pilgrim Rock Management, LLC. Pilgrim Rock is an affiliated management and services company. It will provide intellectual property (IP) licensing, professional and management services, real estate and equipment leasing, and certain other services to Mayflower Medicinals. This past April iAnthus announced the completion of its acquisition of the remaining 20 percent of Pilgrim Rock Management, LLC.

iAnthus Capital Holdings has acquired, through merger and acquisition transactions, largely all the assets of GrowHealthy Holdings, LLC and certain related subsidiaries. The Acquisition completes iAnthus Capital’s full-scale entry into the fast expanding Florida medical cannabis market.

iAnthus Capital Holdings has also acquired Citiva Medical, LLC (Citiva NY), which holds one of the ten vertically integrated medical marijuana "Registered Organization" licenses issued by New York State, and Citiva, LLC (Citiva USA and, together with Citiva NY, Citiva), the owner of certain regulated cannabis industry assets and IP. With the closing of the Citiva acquisition, iAnthus' regulated cannabis industry operations presently encompass six states.

In June, iAnthus Capital Holdings announced that Mayflower Medicinals signed a Host Community Agreement (HCA) with the City of Lowell, Massachusetts, to operate a Medical Marijuana Treatment Center at 450 Chelmsford Street. Lowell, Massachusetts. Mayflower Medicinals’ plan is to pursue a Special Permit at the site. If granted, the dispensary is expected to be one of only two operating dispensaries within the Lowell city limits.

iAnthus Capital Holdings, Inc. (ITHUF), closed Tuesday's trading session at $5.9725, up 0.70%, on 135,145 volume with 408 trades. The average volume for the last 3 months is 293,042 and the stock's 52-week low/high is $1.325/$7.269.

chart

Progressive Care, Inc. (RXMD)

Penny Stock Tweets, Street Register, Wall Street Analyzer, Zacks, First Look Equities, Business Insider, Wallet Investor, SmarterAnalyst, InvestorsHub, ClayTrader, Stockhouse, OTC Markets, SeeThruEquity, TradingView, OTC.Watch, 4-Traders, Insider Financial, and Investors Hangout reported on Progressive Care, Inc. (RXMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Progressive Care, Inc., through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization. It is moving forward in its work to grow the Company by expanding its facility, adding new locations, acquiring operating pharmacies, and further developing its present business lines. Progressive Care is headquartered in North Miami Beach, Florida.

The Company owns PharmCo LLC. PharmCo was formed in 2005 as a Florida Limited Liability Corporation with the aim of becoming a first-rate pharmacy in the South Florida community. PharmCo has developed into a health services enterprise, which centers on the provision of prescription pharmaceuticals.

PharmCo’s compounding department specializes in formularies. These include non-narcotic topical pain creams, wound care creams, scar gels, and hormone replacement therapies. Also, PharmCo offers EnovaRx, which are Food and Drug Administration (FDA) approved manufactured pain creams. These are readily available with a prescription.

Additionally, PharmCo prepares psoriasis creams, wellness vitamins, weight loss formulations and holistic capsules. These are 100 percent Kosher and Halal certified.

In essence, Progressive Care is a provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), and the supply of prescription medications to long term care facilities. Furthermore, the Company is a provider of administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.

Progressive Care opened Smart Medical Alliance, Inc. on September 1, 2016. It opened Smart Medical to assist healthcare providers with navigating the complex risk management environment of their insurance network contracts. Smart Medical Alliance provides management and support services to doctors and administrators under capitated and fee-for-services insurance contracts.

Progressive Care announced this past March that it executed a Letter of Intent (LOI) to purchase a pharmacy in Palm Beach County. The Company signed an LOI on March 1, 2018 to purchase a pharmacy in Palm Beach County for $300,000. This acquisition target is close to major highways in a 3,000 sq. ft facility. The operation has experienced staff, all applicable licenses, as well as commensurate PBM contracts as PharmCo, LLC, and a Parata PASS 500 unit dose packaging system.

This week, Progressive Care announced that it completed the acquisition of a Touchpoint pharmacy in Palm Beach County. This second location will enable Progressive Care’s growth by expanding the delivery radius of the Company’s pharmacy operations to now include Miami-Dade, Broward, Palm Beach and Martin County. In addition, it will reduce costs of expansion of products and services and increase prescription dispensing efficiency.

Progressive Care has added to its increasing fleet of robotic pharmacy equipment. This is with the completion of installation of a TCGRx Automated Pouch Packaging System at the Company’s Miami-Dade County PharmCo location.

Progressive Care has also started developing its own proprietary tele-pharmacy software. This is to digitally communicate with patients, physicians, pharmacists, and caretakers worldwide and expand its kiosk program.

Progressive Care, Inc. (RXMD), closed Tuesday's trading session at $0.07495, up 5.56%, on 693,313 volume with 61 trades. The average volume for the last 3 months is 1,578,389 and the stock's 52-week low/high is $0.012/$0.266.

chart

Force Protection Video Equipment Corp. (FPVD)

AimHighProfits, Promotion Stock Secrets, and Insider Financial reported earlier on Force Protection Video Equipment Corp. (FPVD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Force Protection Video Equipment Corp. (Force Protection) sells high definition (HD) body camera systems and accessories for law enforcement. The Company offers its LE10 Law Enforcement Video Recorder product. Force Protection has its corporate headquarters in Cary, North Carolina.

The Company previously went by the name Enhancer-Your-Reputation.Com, Inc. It changed its name to Force Protection Video Equipment Corp. in March of 2015.

Force Protection has incorporated a wholly-owned subsidiary, CobraXtreme HD Corp., a North Carolina Corporation. This subsidiary’s purpose is to sell HD videos sports cameras and accessories that are alike to those sold by GoPro. Furthermore, it will sell video goggles and sunglass cameras.

CobraXtremeHD also carries a complete line of aftermarket accessories for extreme sports cameras such as GoPro® and Garmin®. The design of CobraXtremeHD cameras are for use in extreme sports.

Force Protection has its LE50 HD Bodycam. The LE50 is a state-of-the-art designed body camera. It is strategically built around Ambarella chip sets (AMBA). Select important design features of the LE50 include industry leading record time (10 hours @1080,12 hours @720); 50 hours of standby time; 32GB of internal tamperproof storage; and white LED illumination.

Concerning the Company’s LE10 Law Enforcement Video Recorder product, it is a small bodyworn HD camera. It is half the size and half the price of most law enforcement cameras now on the market. The LE10 has manifold features. These include still picture ability 8MP, WIFI, 4x zoom, and audio recording. The LE10 does not necessitate special software or costly storage contracts.

In addition, Force Protection released the LE100 and LE101 1080 HD in car video recording dashcam systems. The LE100 and 101 are state-of-the-art designed in-car dash camera systems. They are strategically built around Ambarella A7 chip sets (AMBA).

The Company also has its camera system for Law Enforcement and Security Agencies. The design of the C1, Citadel camera system is to fight and deter graffiti, illegal dumping, and other property crimes. The self-contained system is solar powered. The C1 Citadel requires no external power. All of Force Protection’s cameras and recording devices have FCC, IC and CE certification.

Recently, Force Protection announced the release of the RECON 1000 on the body camera. The RECON 1000 incorporates into its design the Ambarella A7 chip to ensure its optimal performance for law enforcement officers. The RECON 1000 is a robust IP67 camera. It is small, lightweight and full of standard features that cameras twice its size and price do not include.

Force Protection announced in May that it received patent pending status from the U.S. Patent and Trademark Office (USPTO) for its proprietary design titled: Shield Harness for Mounting a Camera. The newly designed product will permit law enforcement departments to use existing body worn cameras with their riot shields to collect evidence during protests and disturbances and also to document inmate extraction in prisons. The design will enable the cameras to be mounted securely and have an unobstructed view point of individuals for later identification and for training.

Force Protection Video Equipment Corp. (FPVD), closed Tuesday's trading session at $0.0002, up 100.00%, on 602,752 volume with 5 trades. The average volume for the last 3 months is 15,622,265 and the stock's 52-week low/high is $0.00009/$0.015.

chart

Nanophase Technologies Corp. (NANX)

Wall Street Resources, SmarTrend Newsletters, Investment Contrarians, RedChip, Profit Confidential, Schaeffer’s, StockEgg, CoolPennyStocks, BullRally, Stock Rich, HotOTC, Penny Invest, and Stealth Stocks reported on Nanophase Technologies Corp. (NANX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Nanophase Technologies Corp. is a technology leader in nanomaterials and advanced nanoengineered products. It provides nanoengineered solutions for many industrial product applications. Nanophase assists its customers in succeeding, with proprietary and patent protected technologies. These technologies allow them to create innovative products. Nanophase Technologies has its corporate office in Romeoville, Illinois.

The Company delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a host of media. It produces engineered nanomaterial products for use in a variety of markets. These markets include Surface Finishing, Exterior Coatings, Personal Care, Plastics, Scratch Resistant Coatings, and Textiles.

Nanophase Technologies’ products include Aluminum Oxide, Antimony Tin Oxide, Bismuth Oxide, Cerium Oxide, Iron Oxide, and Zinc Oxide. Nano metal oxides provide UV protection across plastics, exterior coatings, and textile applications.

Infrared absorbing particles create high clarity, energy saving films and interlayers. The Company creates products with original performance attributes from two ISO 9001:2008 and ISO 14001 facilities. Nanophase Technologies’ nano and submicron Aluminum Oxide imparts scratch resistance to coatings for wood, laminates, packaging, graphic arts, and electronics. Nano metal oxide technology improves the durability and capacity of zinc anode-based batteries.

Regarding nanoparticle production technology, the traditional and most customary manufacturing methods utilized at the Company are plasma-based. The Physical Vapor Synthesis (PVS) and NanoArc® Synthesis (NAS) methods use transferred and non-transferred electric arcs to vaporize precursor materials. These are subsequently carefully condensed to produce nanoparticles with desired properties.

Concerning nanoparticle surface treatment, Nanophase Technologies employs patented and proprietary particle coating technology to tailor the surface of the nanoparticles by discreetly encapsulating individual particles. The process can be used to impart a wide range of functionality to the particles that, in addition to helping to ensure success in the application, provides Nanophase’s customers with a substantial deal of flexibility in formulation with the nanoparticles. The Company can provide the products in dry powder or pre-dispersed formats.

Recently, Nanophase Technologies reported financial results for Q1 ended March 31, 2018. Revenue for Q1 was $2.9 million in 2018 and $3.5 million in 2017. The Net Loss for the quarter was $0.92 million in 2018, or $0.03 per share, versus Net Income of $50K, or $0.00 per share, for 2017. It finished Q1 with roughly $1.2 million in cash and cash equivalents; which included $0.2M of short-term debt.

Nanophase Technologies Corp. (NANX), closed Tuesday's trading session at $0.7938, up 7.27%, on 9,350 volume with 11 trades. The average volume for the last 3 months is 13,376 and the stock's 52-week low/high is $0.355/$1.34.

chart

AXIM Biotechnologies, Inc. (AXIM)

TopPennyStockMovers, CFN Media Group, Promotion Stock Secrets, and SmallCapVoice reported earlier on AXIM Biotechnologies, Inc. (AXIM), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

AXIM Biotechnologies, Inc. is a biotechnology company focusing on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The OTCQB-listed Company discovers and brings to market inventive solutions through research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. AXIM Biotechnologies has its head office in New York, New York. Medical Marijuana, Inc. (MJNA) is a major investor in AXIM.

AXIM Biotechnologies’ focus is on unique, proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is presently no effective treatment. The Company is advancing its patented controlled-release cannabinoid gum in studies covering a number of indications.

AXIM’s IP portfolio now includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain, and 15 patent applications in varying stages of approval.

AXIM’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants. In addition, the Company has its CanChew+ 50®. This product contains 50 mg of CBD. CanChew+ 50®is undergoing clinical trials in patients with IBS (Irritable Bowel Syndrome).

AXIM Biotechnologies’ pipeline of Intellectual Property (IP) protected cannabinoid-based products also includes MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. It is the world’s first patented cannabinoid controlled-release chewing gum.

Medical Marijuana, Inc. (MJNA) announced this past February that its major investment company AXIM Biotechnologies successfully executed its first-ever proprietary current good manufacturing practices (cGMP) methodology in the extraction and microencapsulation of cannabinoid molecules for a variety of pharmaceutical delivery formats from cGMP-produced medicinal cannabis.

This breakthrough makes AXIM Biotechnologies the only Company worldwide with the ability to harness the proprietary procedure and provide Active Pharmaceutical Ingredients (APIs) of such purity from naturally extracted cGMP sources.

Recently, AXIM Biotechnologies announced that the European Patent Office (EPO) published a patent application owned by AXIM for an invention entitled “Anti-Microbial Composition Comprising Cannabinoids,” EU Patent Publication Number 16815133.0. This patent application relates to the formulation of cannabinoid-based products using different delivery methods including spray, cream, liquid, and powder form. The patent application covers numerous cannabinoids.

In May, AXIM Biotechnologies announced that it reached a long-term purchase agreement for pharmaceutical-grade dronabinol with Noramco. The agreement outlines an initial purchase of the Active Pharmaceutical Ingredient (API) dronabinol, which is a synthetic form of tetrahydrocannabinol (THC), to be used in AXIM Biotechnologies’ clinical trials for the treatment of chemotherapy-induced nausea/vomiting (CINV) and anorexia associated with weight loss in patients with cancer or AIDS. Noramco is an international leader in the production of controlled substances for the pharmaceutical industry.

AXIM will microencapsulate the API. It will formulate it into its proprietary controlled-release chewing gum delivery system that will go through an open-label clinical study comparing the bioavailability and therapeutic equivalence of AXIM’s product to the Food and Drug Administration (FDA)-approved reference listed drug (RLD) Marinol®.

Last week, AXIM Biotechnologies announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Application Serial Number 15/146,668, a patent on a methodology developed by AXIM for extraction and purification of the cannabinoid molecule delta-9-tetrahydrocannabinol (THC). A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from the Company’s patent application, filed in May of 2015.

AXIM Biotechnologies, Inc. (AXIM), closed Tuesday's trading session at $1.80, up 0.56%, on 103,355 volume with 185 trades. The average volume for the last 3 months is 104,529 and the stock's 52-week low/high is $1.70/$10.29.

chart

The QualityStocks Company Corner

Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

The expansive cybercrime ecosystem continues to evolve at breakneck speed, and cyberattacks continue to increase globally and to become more complex and ferocious. To prevent these crimes, technology must adapt, and that is the focus of Cyberfort Software, Inc. (OTC: CYBF).

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.185, up 37.04%, on 63,982 volume with 19 trades. The average volume for the last 3 months is 36,000 and the stock's 52-week low/high is $0.0509/$69.00.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Legalization of cannabis is emerging and rising trend, which is influencing many nations to decriminalize cannabis and legalize the use of marijuana for recreational and medicinal purposes.  Active Companies from around the market with current developments this week includes Earth Science Tech Inc. (OTC: ETST).

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $1.89, up 21.94%, on 471,547 volume with 665 trades. The average volume for the last 3 months is 50,846 and the stock's 52-week low/high is $0.421/$1.64.

Recent News

chart

NUGL Inc. (NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry's new standard of technology, today reports its marketing growth for user sign-ups and mobile app downloads has beaten expectations and outperformed industry standards for similarly situated technology start-ups.

NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $2.33, up 12.56%, on 246,233 volume with 334 trades. The average volume for the last 3 months is 172,443 and the stock's 52-week low/high is $0.405/$2.49.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTCQB: SGMD), one of the largest publicly traded hydroponics supply companies, today announces it has issued formal proposals to acquire two hydroponic cultivation supply companies within the fast growing cannabis sector. Sugarmade recently reiterated its 2019 revenue guidance of $30 million representing growth of over 700%, but should these acquisition efforts be successful, the Company would immediately boost its revenue guidance to $75 million for next year, representing one of the fastest revenue growth rates in the cannabis industry. Also today, SGMD was highlighted in an article discussing how, as 2018 heads into the fourth quarter, Cannabidiol – CBD has confidently asserted itself as the most valuable market within the rapidly emerging cannabis industry.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1225, up 12.59%, on 8,058,710 volume with 782 trades. The average volume for the last 3 months is 1,672,018 and the stock's 52-week low/high is $0.028/$0.43.

Recent News

chart

GreenBox POS, LLC (GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

A young man aged 29 was arrested, charged and sentenced to death for being found with a few liters of cannabis oil in Malaysia. Cannabis on all its forms is illegal in this Asian country. However, the uproar about that conviction and sentence has forced the cabinet of that country to have a discussion about decriminalizing marijuana for medical purposes. The discussions going on in Malaysia could be of interest to companies like GreenBox POS, LLC (OTC: GRBX) that would relish the chance to operate in a wider market.

GreenBox POS, LLC (GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.64, up 14.29%, on 20,376 volume with 27 trades. The average volume for the last 3 months is 46,931 and the stock's 52-week low/high is $0.017/$1.95.

Recent News

chart

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Zenosense, Inc. (OTCQB: ZENO), a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held technology for the early detection of heart attack at the Point of Care, is pleased to announce that its MIDS Medical Ltd. joint venture (“JV", “MML") has expanded its technical team to support the next phase of development of MIDS Cardiac. Also today, NetworkNewsWire released a report on the company detailing how ZENO, through the company’s joint venture ownership of MIDS Medical Limited (“MML”), is focused on developing and commercializing its highly sensitive MIDS Cardiac hand-held technology for the rapid, early detection of heart attack at the point of care.

Zenosense, Inc. (ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.32, up 4.58%, on 20,376 volume with 20 trades. The average volume for the last 3 months is 46,931 and the stock's 52-week low/high is $0.15/$0.895.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) was highlighted today in an article on the booming lithium market. Despite short-term gyrations, the outlook for lithium continues to shine. Electric mobility is still only in its infancy. Revolutionizing how we commute and power our lives, the inevitable tsunami of electric vehicles and burgeoning demand for energy grid storage are driving lithium demand for the foreseeable future.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.213, up 1.91%, on 197,800 volume with 65 trades. The average volume for the last 3 months is 102,448 and the stock's 52-week low/high is $0.125/$1.46.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (KBEVF).

Koios Beverage Corp. (CSE:KBEV)(OTC: KBEVF) (the "Company" or "Koios") is pleased to announce its proprietary nootropic drinks and supplements are now for sale at Alfalfa's Market, a Colorado institution and early adopter of natural and organic groceries. Also today, CannabisNewsWire issued a report featuring the company which discusses the case of a young man aged 29 who was arrested, charged and sentenced to death for being found with a few liters of cannabis oil in Malaysia. Cannabis on all its forms is illegal in this Asian country. However, the uproar about that conviction and sentence has forced the cabinet of that country to have a discussion about decriminalizing marijuana for medical purposes.

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (KBEVF), closed the day's trading session at $0.51, up 1.98%, on 432,845 volume with 218 trades. The average volume for the last 3 months is 507,752 and the stock's 52-week low/high is $0.001/$0.814.

Recent News

chart

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA), an innovative hemp and cannabis corporation, and its joint venture partner Global Hemp Group Inc. (CSE: GHG/ OTC: GBHPF/ FRANKFURT: GHG) (the “Partners”) are pleased to provide an update on their high yielding CBD hemp project in Scio, Oregon. Also today, the company was highlighted in an article discussing how the legalization of cannabis is an emerging and rising trend, which is influencing many nations to decriminalize cannabis and legalize the use of marijuana for recreational and medicinal purposes.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.026, off by 1.89%, on 9,669,108 volume with 453 trades. The average volume for the last 3 months is 7,815,403 and the stock's 52-week low/high is $0.022/$0.0728.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Phivida Holdings Inc. (CSE: VIDA OTCQX: PHVAF) ("Phivida"), is pleased to see the decision by the U.S. Drug Enforcement Administration (DEA) to remove the cannabis component cannabidiol (CBD) from its Schedule 1 list of controlled substances. The DEA defines Schedule 1 as a list of controlled substances with no currently accepted medical use and a high potential for abuse. CBD, when contained in "finished dosage formulations" has now been moved to Schedule 5, defined as drugs with lower potential for abuse. The ruling does not broadly apply to CBD. Also today, NetworkNewsWire released a report on the company detailing how PHVAF this morning issued a response to the U.S. Drug Enforcement Administration’s recent decision to remove cannabis component cannabidiol from its Schedule I list of controlled substances. To view the full press release, visit: http://nnw.fm/Y6vp9.

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.

Regulations

Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.

WeedMD-Phivida

Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.8089, off by 5.29%, on 152,726 volume with 109 trades. The average volume for the last 3 months is 89,895 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

665 Energy (SSOF)

The QualityStocks Daily Newsletter would like to spotlight 665 Energy (SSOF).

For almost sixty years, 665 Energy (OTC: SSOF), formerly Sixty Six Oilfield Services, has held its position as a top industry expert in the drilling equipment sector of the oil and gas industry. To view the full article, visit: http://nnw.fm/xUo6q.

Headquartered in Oklahoma City, 665 Energy (SSOF), formerly Sixty Six Oilfield Services, has been a leading industry expert in the drilling equipment sector of the oil and gas industry for nearly six decades. The company’s sales and rental department provides solutions for domestic and international markets with core offerings that include a wide variety of customized drilling rigs and other select equipment.

665 Energy recently completed the acquisition of Fluid End Sales, doing business as Five Star Rig and Supply, which was established as a family owned business in 1984. The company’s focus continues to be on supplying the oil industry with custom drilling rigs, heavy-weight drill pipe, drill collars, pup joints, pony collars, handling tools, tubing, casing, blow-out preventers, engines, compressors and other select equipment to customers worldwide through its facilities in Oklahoma, Germany and Dubai. The company’s services include the sale of new equipment, sale of refurbished and certified used equipment, as well as rental of oilfield equipment.

Immediate expansion plans include partnering with a rig debt financing company to fund the $40 million purchase of 11 identified oil drilling rigs that have already been appraised. This action represents an incredible opportunity to jumpstart the next phase of growth and expansion.

Company president and CEO Jason Clayton, who started at Five Star in 1993, has worked in and managed all areas of the company including customer growth and sales. Clayton will also remain as president of the subsidiary, Five Star Rig and Supply, and is supported by longtime key staff members including Jimmy Joslin, who has been with Five Star Rig since 1984 and will be responsible for orders processing, inventory control, delivery, logistics and supervision of custom projects such as rig and rig equipment refurbishment, testing and certification. Jim Frazier will assume the role of CFO as the company prepares for further growth and expansion.

According to a research report by Statista, the world’s oil and gas equipment industry is projected to be worth nearly USD$205 billion by 2020 (http://nnw.fm/BzFl8), and as the energy sector continues strong growth in 2018, 665 Energy is well positioned to capitalize on the global trend and will continue to be aggressive in the marketplace.

665 Energy (SSOF), closed the day's trading session at $0.0073, up 4.29%, on 1,430,984 volume with 15 trades. The average volume for the last 3 months is 3,460,383 and the stock's 52-week low/high is $0.0006/$0.019.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce and mobile devices, announced that it has entered into a memorandum of understanding with Bank Sputnik to launch a technology platform expected to provide a suite of frictionless payment acceptance services for financial institutions and value-added providers. Bank Sputnik provides a full range of banking services to businesses. 

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $4.75, off by 11.21%, on 149,921 volume with 770 trades. The average volume for the last 3 months is 95,723 and the stock's 52-week low/high is $3.47/$33.515.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce the closing of the previously announced acquisition of HemPoland. The transaction has received approval from the Toronto Stock Exchange and cements the Company's commitment to building shareholder value through international expansion. Also today, NetworkNewsWire released a report on the company detailing TGODF’s launch of its premium, certified organic cannabis brand - a significant step toward the company’s goal of becoming the world’s largest organic cannabis brand.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $4.68, off by 10.66%, on 1,530,292 volume with 3,753 trades. The average volume for the last 3 months is 860,367 and the stock's 52-week low/high is $2.784/$7.565.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

CannabisNewsAudio announces the Audio Press Release (APR) titled “CBD Supplements Primed to Explode Ahead of Biopharma as Farm Bill Legalizes Hemp,” featuring Youngevity International, Inc. (NASDAQ: YGYI). To hear the CannabisNewsAudio version, visit: http://cnw.fm/7WNjS. To read the full editorial, visit: http://cnw.fm/iR532. Also today, NetworkNewsWire released a report on the company detailing how YGYI’s wholly-owned subsidiary, CLR Roasters, will be shipping coffee earlier than anticipated for its recently entered 5-year sale and processing contract which is estimated to be worth $250 million.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $2.91, up 8.38%, on 19,396 volume with 109 trades. The average volume for the last 3 months is 55,928 and the stock's 52-week low/high is $2.44/$8.20.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.